| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.4 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |